GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Fortis Healthcare Ltd

Fortis Healthcare: Board Approves Dr. Raghuvanshi's Re-appointment as MD & CEO

BOARD ▲ Positive Development LOW RISK
📅 Filed on BSE: 08 Jul 2026, 02:41 PM IST  ·  BSE ID: 760d49e5-4222-4637-bec6-c767098a6452
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board wants to keep its top executive, Dr. Raghuvanshi, for two more years, pending shareholder agreement.
🤖 AI Summary
  • Fortis Healthcare board approved Dr. Raghuvanshi's re-appointment as MD & CEO.
  • The new term is for two years, effective March 19, 2027.
  • Shareholder approval is required for this re-appointment to be finalized.
  • Dr. Raghuvanshi is not barred from capital markets or director positions.
🏢 How This Affects the Company
📈
Business Impact
Ensures continuity in leadership and strategic direction for Fortis Healthcare, supporting ongoing business operations and growth initiatives.
💰
Financial Impact
No direct financial impact stated. Re-appointment pertains to executive leadership.
⚙️
Operational Impact
Maintains stability in executive management, impacting strategic decision-making and operational oversight.
⚠️
Risk Impact
Reduces leadership transition risk by confirming a known executive's continued role.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to vote on the proposed re-appointment at the upcoming General Meeting.
👤
Who Is Affected
All shareholders of Fortis Healthcare will be affected as they will have the opportunity to vote on the re-appointment.
🔍
Management Signal
The board's decision signals confidence in Dr. Raghuvanshi's leadership and commitment to continuity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder meeting announcement for re-appointment vote.
Outcome of shareholder vote on re-appointment.
Announcement of Dr. Raghuvanshi's new employment contract details.
LOW RISK Board decision on executive re-appointment involves standard corporate governance procedures.
💡 Investor Takeaway
Fortis Healthcare's Board approved Dr. Ashutosh Raghuvanshi's re-appointment as MD & CEO for two years from March 19, 2027, subject to shareholder approval.
❓ Frequently Asked Questions
Who has Fortis Healthcare's Board approved for re-appointment?
The Board has approved the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director and Chief Executive Officer.
What is the duration of Dr. Ashutosh Raghuvanshi's re-appointed tenure at Fortis Healthcare?
Dr. Raghuvanshi's re-appointment is for a further period of two years, effective from March 19, 2027.
Is Dr. Ashutosh Raghuvanshi allowed to hold a directorial position?
Yes, Dr. Ashutosh Raghuvanshi is not debarred from accessing capital markets or holding any position/office of director.
What is required for Dr. Ashutosh Raghuvanshi's re-appointment to be effective?
The re-appointment is subject to the approval of shareholders of Fortis Healthcare Limited.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.